New Multiple Myeloma Treatments

The prognosis for multiple myeloma has improved significantly due to recent advances in treatment for myeloma. Nevertheless, the vast majority of myeloma patients relapse, which is why a critical need exists for new multiple myeloma treatments. Multiple myeloma treatment research continues, with dozens of new treatments at various stages of development and testing.

Testing New Drug Treatment for Myeloma

Carfilzomib is a new drug that appears to induce cancer cell death and inhibit the growth of myeloma tumors. Carfilzomib is a proteasome inhibitor like bortezomib (Velcade